These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 28444691)

  • 21. MAN1B1-CDG: Three new individuals and associated biochemical profiles.
    Sakhi S; Cholet S; Wehbi S; Isidor B; Cogne B; Vuillaumier-Barrot S; Dupré T; Detleft T; Schmitt E; Leheup B; Bonnet C; Feillet F; Muti C; Fenaille F; Bruneel A
    Mol Genet Metab Rep; 2021 Sep; 28():100775. PubMed ID: 34141584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Normal transferrin patterns in congenital disorders of glycosylation with Golgi homeostasis disruption: apolipoprotein C-III at the rescue!
    Raynor A; Vincent-Delorme C; Alaix AS; Cholet S; Dupré T; Vuillaumier-Barrot S; Fenaille F; Besmond C; Bruneel A
    Clin Chim Acta; 2021 Aug; 519():285-290. PubMed ID: 34022244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypothesis: lobe A (COG1-4)-CDG causes a more severe phenotype than lobe B (COG5-8)-CDG.
    Haijes HA; Jaeken J; Foulquier F; van Hasselt PM
    J Med Genet; 2018 Feb; 55(2):137-142. PubMed ID: 28848061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Congenital disorders of glycosylation with emphasis on cerebellar involvement.
    Barone R; Fiumara A; Jaeken J
    Semin Neurol; 2014 Jul; 34(3):357-66. PubMed ID: 25192513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased Clinical Sensitivity and Specificity of Plasma Protein
    Chen J; Li X; Edmondson A; Meyers GD; Izumi K; Ackermann AM; Morava E; Ficicioglu C; Bennett MJ; He M
    Clin Chem; 2019 May; 65(5):653-663. PubMed ID: 30770376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transferrin mutations at the glycosylation site complicate diagnosis of congenital disorders of glycosylation type I.
    Guillard M; Wada Y; Hansikova H; Yuasa I; Vesela K; Ondruskova N; Kadoya M; Janssen A; Van den Heuvel LP; Morava E; Zeman J; Wevers RA; Lefeber DJ
    J Inherit Metab Dis; 2011 Aug; 34(4):901-6. PubMed ID: 21431619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transferrin and apolipoprotein C-III isofocusing are complementary in the diagnosis of N- and O-glycan biosynthesis defects.
    Wopereis S; Grünewald S; Huijben KM; Morava E; Mollicone R; van Engelen BG; Lefeber DJ; Wevers RA
    Clin Chem; 2007 Feb; 53(2):180-7. PubMed ID: 17170056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new strategy implementing mass spectrometry in the diagnosis of congenital disorders of N-glycosylation (CDG).
    Casetta B; Malvagia S; Funghini S; Martinelli D; Dionisi-Vici C; Barone R; Fiumara A; Donati MA; Guerrini R; la Marca G
    Clin Chem Lab Med; 2020 Aug; 59(1):165-171. PubMed ID: 32776892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Compound heterozygous variants in MAN2B2 identified in a Chinese child with congenital disorders of glycosylation.
    Tian Q; Shu L; Shu C; Xi H; Ma N; Mao X; Wang H
    Eur J Hum Genet; 2023 Dec; 31(12):1455-1457. PubMed ID: 35637269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Novel N-Tetrasaccharide in Patients with Congenital Disorders of Glycosylation, Including Asparagine-Linked Glycosylation Protein 1, Phosphomannomutase 2, and Mannose Phosphate Isomerase Deficiencies.
    Zhang W; James PM; Ng BG; Li X; Xia B; Rong J; Asif G; Raymond K; Jones MA; Hegde M; Ju T; Cummings RD; Clarkson K; Wood T; Boerkoel CF; Freeze HH; He M
    Clin Chem; 2016 Jan; 62(1):208-17. PubMed ID: 26430078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mass spectrometry for congenital disorders of glycosylation, CDG.
    Wada Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jun; 838(1):3-8. PubMed ID: 16517226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N-glycome analysis detects dysglycosylation missed by conventional methods in SLC39A8 deficiency.
    Park JH; Mealer RG; Elias AF; Hoffmann S; Grüneberg M; Biskup S; Fobker M; Haven J; Mangels U; Reunert J; Rust S; Schoof J; Schwanke C; Smoller JW; Cummings RD; Marquardt T
    J Inherit Metab Dis; 2020 Nov; 43(6):1370-1381. PubMed ID: 32852845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insights into complexity of congenital disorders of glycosylation.
    Goreta SS; Dabelic S; Dumic J
    Biochem Med (Zagreb); 2012; 22(2):156-70. PubMed ID: 22838182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A rapid mass spectrometric strategy for the characterization of N- and O-glycan chains in the diagnosis of defects in glycan biosynthesis.
    Faid V; Chirat F; Seta N; Foulquier F; Morelle W
    Proteomics; 2007 Jun; 7(11):1800-13. PubMed ID: 17520685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apolipoprotein C-III isofocusing in the diagnosis of genetic defects in O-glycan biosynthesis.
    Wopereis S; Grünewald S; Morava E; Penzien JM; Briones P; García-Silva MT; Demacker PN; Huijben KM; Wevers RA
    Clin Chem; 2003 Nov; 49(11):1839-45. PubMed ID: 14578315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How Golgi glycosylation meets and needs trafficking: the case of the COG complex.
    Reynders E; Foulquier F; Annaert W; Matthijs G
    Glycobiology; 2011 Jul; 21(7):853-63. PubMed ID: 21112967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new inborn error of glycosylation due to a Cog8 deficiency reveals a critical role for the Cog1-Cog8 interaction in COG complex formation.
    Foulquier F; Ungar D; Reynders E; Zeevaert R; Mills P; García-Silva MT; Briones P; Winchester B; Morelle W; Krieger M; Annaert W; Matthijs G
    Hum Mol Genet; 2007 Apr; 16(7):717-30. PubMed ID: 17220172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COG6-CDG: Novel variants and novel malformation.
    Cirnigliaro L; Bianchi P; Sturiale L; Garozzo D; Mangili G; Keldermans L; Rizzo R; Matthijs G; Fiumara A; Jaeken J; Barone R
    Birth Defects Res; 2022 Mar; 114(5-6):165-174. PubMed ID: 35068072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry to Detect Diagnostic Glycopeptide Markers of Congenital Disorders of Glycosylation.
    Wada Y
    Mass Spectrom (Tokyo); 2020; 9(1):A0084. PubMed ID: 32547898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dissecting Total Plasma and Protein-Specific Glycosylation Profiles in Congenital Disorders of Glycosylation.
    Hipgrave Ederveen AL; de Haan N; Baerenfaenger M; Lefeber DJ; Wuhrer M
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33076454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.